Literature DB >> 9134039

Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas.

N C Hunt1, A G Douglas-Jones, B Jasani, J M Morgan, M Pignatelli.   

Abstract

The National Breast Screening Programme affords the opportunity to study breast carcinomas at an early stage in their development. E-cadherin is a calcium-dependent, intercellular adhesion molecule whose loss of expression may facilitate the processes of invasion and metastasis of some human tumours. From a group of screen-detected ductal carcinomas less than or equal to 10 mm in diameter, 16 with lymph node metastasis were identified and matched for grade, size and patient age with node negative tumours. The level of expression of E-cadherin (detected by immunocytochemistry) was compared in the matched pairs using a simple semi-quantitative intensity distribution scoring system. The results showed a significant (P = 0.05 Wilcoxon paired rank test) reduction of E-cadherin expression in tumours with lymph node metastases compared to those without. In the context of the small size of these tumours it is proposed that these results support the hypothesis that reduction in E-cadherin expression is an early event in the development of metastases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134039     DOI: 10.1007/bf01092751

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  Effect of calcium on e-cadherin expression in breast-tumor cells.

Authors:  B Vandewalle; F Revillion; P Doutrelant; A Granier; J Lefebvre
Journal:  Int J Oncol       Date:  1994-01       Impact factor: 5.650

2.  Comparative study of the histopathology of breast cancer in a screened and unscreened population investigated by mammography.

Authors:  N M Gibbs
Journal:  Histopathology       Date:  1985-12       Impact factor: 5.087

3.  Expression of e-cadherin and alpha-catenin molecules in human breast-cancer tissues and association with clinicopathological features.

Authors:  T Takayama; H Shiozaki; M Inoue; S Tamura; H Oka; T Kadowaki; Y Takatsuka; A Nagafuchi; S Tsukita; T Mori
Journal:  Int J Oncol       Date:  1994-10       Impact factor: 5.650

Review 4.  E-cadherin and its associated protein catenins, cancer invasion and metastasis.

Authors:  W G Jiang
Journal:  Br J Surg       Date:  1996-04       Impact factor: 6.939

5.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

6.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Authors:  R Moll; M Mitze; U H Frixen; W Birchmeier
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

7.  Prognostic value of E-cadherin expression in 413 gastric carcinomas.

Authors:  H E Gabbert; W Mueller; A Schneiders; S Meier; R Moll; W Birchmeier; G Hommel
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

8.  Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA.

Authors:  A Nagafuchi; Y Shirayoshi; K Okazaki; K Yasuda; M Takeichi
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

9.  Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.

Authors:  C J Vessey; J Wilding; N Folarin; S Hirano; M Takeichi; P Soutter; G W Stamp; M Pignatelli
Journal:  J Pathol       Date:  1995-06       Impact factor: 7.996

10.  E-cadherin expression in basal cell carcinoma.

Authors:  A Pizarro; N Benito; P Navarro; J Palacios; A Cano; M Quintanilla; F Contreras; C Gamallo
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  26 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

3.  Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.

Authors:  Q Meng; J Xu; I D Goldberg; E M Rosen; R A Greenwald; S Fan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.

Authors:  Hui-Ming Dong; Gang Liu; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Jian-Min Luo; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-24       Impact factor: 4.553

5.  Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.

Authors:  Aleksandra Markiewicz; Marzena Wełnicka-Jaśkiewicz; Barbara Seroczyńska; Jarosław Skokowski; Hanna Majewska; Jolanta Szade; Anna J Żaczek
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

6.  Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.

Authors:  Yu Deng; Hui Deng; Jing Liu; Gangwen Han; Stephen Malkoski; Bolin Liu; Rui Zhao; Xiao-Jing Wang; Qinghong Zhang
Journal:  Mol Carcinog       Date:  2011-06-16       Impact factor: 4.784

7.  Biomarkers for EMT and MET in breast cancer: An update.

Authors:  Fei Liu; Li-Na Gu; Bao-En Shan; Cui-Zhi Geng; Mei-Xiang Sang
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

8.  Elevated expression of E-cadherin in primary breast cancer and its corresponding metastatic lymph node.

Authors:  Lin Chen; Wei Jian; Leisheng Lu; Lijun Zheng; Zhen Yu; Donglei Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 9.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression.

Authors:  Liangsheng Fan; Hongyan Wang; Xi Xia; Yumei Rao; Xiangyi Ma; Ding Ma; Peng Wu; Gang Chen
Journal:  Oncol Lett       Date:  2012-09-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.